A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters
Mao‐xu Ge(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongwei He(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 37
Related Papers
Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells
|Hepatology|2010|116
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway
|Acta Pharmacologica Sinica|2015|67
The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy
|British Journal of Pharmacology|2017|65